A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Clinical trial NCT03241173 · COMPLETED
Trial details
- NCT number
- NCT03241173
- Sponsor
- Incyte Biosciences International Sàrl
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2019-09-17
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.